Pilot Awards Recipients Archive

The DC CFAR has funded a wide variety of research, including basic, clinical, epidemiologic, social behavioral and prevention HIV/AIDS science since 2017.

Alt Text

Pilot Award Recipient: Jose Bordon, PhD

The introduction of combination anti-retroviral therapy (ART) resulted in dramatic reductions in AIDS-related mortality and improvements in the prognosis for HIV-infected patients.

Alt Text

Pilot Award Recipient: Ian Toma, PhD, MD

The project is aimed at identification of transcripts (genes) differentially expressed in the umbilical cord blood of neonates born to HIV infected and uninfected women.

Alt Text

Pilot Award Recipient: Dana Hines, PhD, MSN, BSN

Transgender people account for an estimated 2.8% of the population in the District of Columbia (DC), however, account for approximately 2% of the population living with HIV.

Alt Text

Pilot Award Recipient: Deborah Goldstein, MD

The transfemale community, and especially transwomen of color, in Washington, DC bear a disproportionate burden of  HIV infection.

Alt Text

Pilot Award Recipient: Richard Apps, PhD

Over the past decade HLA-C, the least polymorphic classical HLA class-I molecule, has been found to influence HIV-1 disease.

Alt Text

Pilot Award Recipient: Raymond Scott Turner, PhD

Despite significant advances in medical treatment, approximately half of patients with HIV-infection are affected by reduced brain functions.

Alt Text

Pilot Award Recipient: Leah Squires, PhD

The goal of this study is to find out if a short questionnaire can identify men who have experienced intimate partner violence (IPV).

Alt Text

Pilot Award Recipient: Marina Jerebtsova, PhD

In HIV-infected patients on antiretroviral therapy pulmonary complications have been shifted from opportunistic infections to non-communicable disease.

Alt Text

Pilot Award Recipient: Sarah Calabrese, PhD

This one year pilot pilot award will study PrEP social marketing to Black MSM in Washington, DC.

Alt Text

Pilot Award Recipient: Jeffrey Bethony, MD, PhD

This one year pilot study explores recent advances in HIV vaccines that focus on inducing “broadly neutralizing antibodies” (bNAbs).